Angioscopic assessment of arterial repair following biodegradable polymer-coated biolimus A9-eluting stent implantation - Comparison with durable polymer-coated sirolimus-eluting stent

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1113-1119

  Awata, Masaki ^a   Uematsu, Masaaki ^a   Sera, Fusako ^a   Ishihara, Takayuki ^a   Watanabe, Tetsuya ^a   Fujita, Masashi ^a   Onishi, Toshinari ^a   Iida, Osamu ^a   Ishida, Yoshio ^a   Nanto, Shinsuke ^b   Nagata, Seiki ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioscopy; Biodegradable polymer; Biolimus A9; Durable polymer; Neointima

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; POLYMER; RAPAMYCIN; RAPAMYCIN DERIVATIVE; TICLOPIDINE; UMIROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOSCOPY; ARTERY RECONSTRUCTION; ARTICLE; BIODEGRADABLE IMPLANT; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; QUANTITATIVE STUDY; RIGHT CORONARY ARTERY; RISK FACTOR; SMOKING; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

AGED, 80 AND OVER; ANGIOSCOPY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMERS; SIROLIMUS; TREATMENT OUTCOME; TUNICA INTIMA; WOUND HEALING;

EID: 79955697140     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0776     Document Type: Article

References (35)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004; 109: 1942-1947.
3. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701-705.
4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
5. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
6. Grube E, Buellesfeld L. BioMatrix Biolimus A9-eluting coronary stent: A next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 2006; 3: 731-741.
7. Ostojic M, Sagic D, Jung R, Zhang YL, Nedeljkovic M, Mangovski L, et al. The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: The NOBORI PK study. Catheter Cardiovasc Interv 2008; 72: 901-908.
8. Sakai S, Mizuno K, Yokoyama S, Tanabe J, Shinada T, Seimiya K, et al. Morphologic changes in infarct-related plaque after coronary stent placement: A serial angioscopy study. J Am Coll Cardiol 2003; 42: 1558-1565.
9. Haase J, Escaned J, van Swijndregt EM, Ozaki Y, Gronenschild E, Slager CJ, et al. Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn 1993; 30: 104-114.
10. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
11. Awata M, Kotani J, Nanto S, Uematsu M, Morozumi T, Hori M, et al. Sustained attenuation of neointimal coverage over the stent following brachytherapy for in-stent restenosis: Angioscopic findings. Circ J 2006; 70: 846-850.
12. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: Comparison with bare-metal stents. Circulation 2007; 116: 910-916.
13. Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents. J Am Coll Cardiol 2008; 52: 789-790.
14. Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: Comparison with sirolimus-eluting stents. J Am Coll Cardiol Intv 2009; 2: 453-458.
15. Sera F, Awata M, Uematsu M, Kotani J, Nanto S, Nagata S. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy. J Am Coll Cardiol Intv 2009; 2: 989-994.
16. den Heijer P, Foley DP, Hillege HL, Lablanche JM, van Dijk RB, Franzen D, et al. The 'Ermenonville' classification of observations at coronary angioscopy: Evaluation of intra- and inter-observer agreement: European Working Group on Coronary Angioscopy. Eur Heart J 1994; 15: 815-822.
17. Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K. The healing process of infarct-related plaques: Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 2001; 38: 1916-1922.
18. Takano M, Mizuno K, Yokoyama S, Seimiya K, Ishibashi F, Okamatsu K, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: Serial evaluation by coronary angioscopy. J Am Coll Cardiol 2003; 42: 680-686.
19. Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, et al. Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: The Nobori 1 trial. EuroIntervention 2007; 2: 426-434.
20. Ostojic M, Sagic D, Beleslin B, Jung R, Perisic Z, Jagic N, et al. First clinical comparison of Nobori -Biolimus A9 eluting stents with Cypher-Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes. EuroIntervention 2008; 3: 574-579.
21. Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, et al. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: The NOBORI 1 trial: Phase 2. Circ Cardiovasc Interv 2009; 2: 188-195.
22. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
23. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 1030-1039.
24. Takano M, Mizuno K. Late coronary thrombosis in a sirolimuseluting stent due to the lack of neointimal coverage. Eur Heart J 2006; 27: 1133.
25. Takano M, Yamamoto M, Mizuno K. Two cases of coronary stent thrombosis very late after bare-metal stenting. J Am Coll Cardiol Intv 2009; 2: 1286-1287.
26. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701-1706.
27. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994; 23: 341-346.
28. Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: An angioscopic study. J Am Coll Cardiol Img 2009; 2: 616-624.
29. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 2006; 27: 2189-2195.
30. Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, et al. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 2009; 73: 718-725.
31. Komiyama N. Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging. Circ J 2009; 73: 628-629.
32. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: Multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009; 73: 2110-2117.
33. Kodama K, Komatsu S, Ueda Y, Takayama T, Yajima J, Nanto S, et al. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound: The TOGETHAR trial. Circ J 2010; 74: 1922-1928.
34. Takano M, Mizuno K. Coronary angioscopic evaluation for serial changes of luminal appearance after pharmacological and catheter interventions. Circ J 2010; 74: 240-245.
35. Takano M, Yamamoto M, Murakami D, Inami S, Okamatsu K, Seimiya K, et al. Lack of association between large angiographic late loss and low risk of in-stent thrombus: Angioscopic comparison between paclitaxel- and sirolimus-eluting stents. Circ Cardiovasc Interv 2008; 1: 20-27.